Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$423.04
-0.2%
$398.72
$289.36
$425.35
$137.60B1.432.46 million shs1.57 million shs
Pharmerica Co. stock logo
PMC
Pharmerica
$0.00
$22.00
$29.50
N/AN/A283,015 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
-0.16%+4.74%+4.47%+10.54%+24.61%
Pharmerica Co. stock logo
PMC
Pharmerica
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.4808 of 5 stars
2.43.02.53.02.52.52.5
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.75
Moderate Buy$434.932.81% Upside
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/A

Current Analyst Ratings

Latest OCI, NBLS, GS, PMC, and WGB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$460.00 ➝ $470.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$349.00 ➝ $360.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$410.00 ➝ $425.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$435.00 ➝ $440.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$390.00 ➝ $405.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$424.00 ➝ $433.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$446.00 ➝ $479.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$450.00 ➝ $478.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$465.00
4/9/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$440.00 ➝ $460.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$108.42B1.27$40.91 per share10.34$363.61 per share1.16
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.52B$25.6116.5210.911.368.17%8.65%0.58%7/17/2024 (Estimated)
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest OCI, NBLS, GS, PMC, and WGB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/15/2024Q1 2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.54$11.58+$3.04$11.58$12.94 billion$14.21 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$11.002.60%+28.06%42.95%3 Years
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/A

Latest OCI, NBLS, GS, PMC, and WGB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Quarterly$2.752.77%5/30/20245/30/20246/27/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
1.98
1.12
0.76
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Pharmerica Co. stock logo
PMC
Pharmerica
89.97%

Insider Ownership

CompanyInsider Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.54%
Pharmerica Co. stock logo
PMC
Pharmerica
5.04%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
45,300324.53 million322.78 millionOptionable
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/ANot Optionable

OCI, NBLS, GS, PMC, and WGB Headlines

SourceHeadline
Medicine shortage hits TB elimination programme in PuneMedicine shortage hits TB elimination programme in Pune
msn.com - March 30 at 4:53 PM
From next month, PMC hospitals, maternity homes to get generic medicine storesFrom next month, PMC hospitals, maternity homes to get generic medicine stores
msn.com - November 22 at 6:36 AM
Davenport Extreme Pools & Spas owner and spouse charged with fraud, theftDavenport Extreme Pools & Spas owner and spouse charged with fraud, theft
bizjournals.com - October 6 at 6:03 PM
PMC Prodigy 1 reviewPMC Prodigy 1 review
whathifi.com - September 14 at 10:50 PM
Pharmerica Stock Falls On Unusually High Volume (PMC)Pharmerica Stock Falls On Unusually High Volume (PMC)
thestreet.com - May 25 at 8:22 AM
Top Stories: Patient information exposed in PharMerica breachTop Stories: Patient information exposed in PharMerica breach
healthcarefinancenews.com - May 24 at 8:39 PM
PharMerica Notifies 5.8M Individuals of Healthcare Data BreachPharMerica Notifies 5.8M Individuals of Healthcare Data Breach
healthitsecurity.com - May 19 at 12:25 PM
Activities of Daily Living for SeniorsActivities of Daily Living for Seniors
health.usnews.com - April 20 at 2:20 AM
We can howl about staffing challenges, or start fixing themWe can howl about staffing challenges, or start fixing them
mcknights.com - April 18 at 12:13 AM
PAC Profile: Pharmerica CorpPAC Profile: Pharmerica Corp
opensecrets.org - April 18 at 12:13 AM
Golden LivingGolden Living
forbes.com - February 24 at 12:56 AM
Gas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028Gas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028
marketwatch.com - January 17 at 9:51 AM
Kentucky orthopedic practice to relocateKentucky orthopedic practice to relocate
beckersspine.com - December 27 at 2:02 PM
Gas Cylinders Market is Estimated to Accelerate Industry Development in Machinery & Equipment Sector with Top Key Players till 2028Gas Cylinders Market is Estimated to Accelerate Industry Development in Machinery & Equipment Sector with Top Key Players till 2028
marketwatch.com - November 10 at 9:28 PM
9 Medford Residents To Participate In 2022 Pan-Mass Challenge9 Medford Residents To Participate In 2022 Pan-Mass Challenge
msn.com - July 15 at 3:50 PM
Zero tolerance policy on irregularities in medical education system: PMCZero tolerance policy on irregularities in medical education system: PMC
app.com.pk - June 25 at 1:10 PM
PMC among nation’s top-performing hospitals for treatment of heart attack patientsPMC among nation’s top-performing hospitals for treatment of heart attack patients
news-expressky.com - May 25 at 7:28 PM
CVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7BCVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7B
thestreet.com - January 21 at 8:53 PM
View | PMC Bank rescue blueprint: let bail-in not be resurrected surreptitiouslyView | PMC Bank rescue blueprint: let bail-in not be resurrected surreptitiously
msn.com - December 8 at 1:05 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

The Goldman Sachs Group logo

The Goldman Sachs Group

NYSE:GS
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.
Pharmerica logo

Pharmerica

NYSE:PMC
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.